The Academy

Research Day is a daylong event for basic scientists and clinicians to spur interdisciplinary collaboration. The event will feature a keynote, data blitzes, special seminars, a shark tank-style pitch competition, and networking sessions.


Schedule of the Day

Event Flow

7:00-7:50 a.m.
Early Bird Data Blitzes

8:00 – 8:30 a.m.
Doors, Registration, Breakfast

8:30 – 9:00 a.m.
Research Day Kickoff and Welcome 

9 – 10:15 a.m.
Data Blitz Sessions

10:15 – 10:30 a.m.
Special Session - Hypoxia 
Location: North Annex

10:30 - 11:45 a.m.
Data Blitz Sessions

11:45 a.m. - 12:30 p.m.
Lunch and Scholarly Projects Poster Session
Posters Location: North Annex
Lunch Location: Forum

12:30 p.m. - 1:15 p.m.
Keynote Lecture
All of Us Research Program – A Platform to Transform Biomedical Research
Joshua Denny, MD, MS - CEO, NIH All of Us Research Program

1:30 p.m. - 2:45 p.m.
Data Blitz Sessions

2:45 p.m.
Special Session
CMM High Res Imaging
Medical Imaging 

Location: HSIB North Annex

3:15 p.m. - 4:45 p.m.
Shark Tank Pitch Competition
Location: HSIB Forum

4:45 - 6:30 p.m.
Research Day Reception with MD/PhD Spotlights
LocationHSIB North Annex

7:00 p.m.
Event End

 


Keynote Speaker

Josh Denny, MD, MS, is the Chief Executive Officer of the National Institutes of Health’s All of Us Research Program. He has been involved in All of Us from its inception, first as a member of the Advisory Committee to the (NIH) Director Precision Medicine Initiative Working Group, which developed the program’s initial scientific blueprint. He led the program’s initial prototyping project and served as the principal investigator for the All of Us Data and Research Center. 

As a physician-scientist, Josh is deeply committed to improving patient care through the advancement of precision medicine. Before joining the NIH, Josh was a Professor of Biomedical Informatics and Medicine, Director of the Center for Precision Medicine, and Vice President for Personalized Medicine at Vanderbilt University Medical Center. In his roles at VUMC, he was both a practicing internist and a researcher. His research interests include the use of electronic health records (EHRs) and genomics to better understand disease and drug response. He also led efforts implementing precision medicine to improve patient outcomes. Josh was a leader in the development of phenome‐wide association studies (PheWAS) and phenotype risk scores.